GlassScriptPhysician profile
John L Murray
NPI 1730614736
$2,220.19
in general payments reported to CMS, 2019-2025
26 companies · $1,076 in 2025
The $1,076 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25.00 · 2023: $337 · 2024: $782 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,175 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,175.19 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $372.19 | 2020-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $355.02 | 2023-2025 | Lifevest |
| Abiomed | $259.95 | 2023-2025 | Impella |
| Medtronic, INC. | $232.56 | 2024-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan, Signia |
| Smoky Mountain Surgical LLC | $124.87 | 2024-2025 | |
| Baxter Healthcare | $122.57 | 2023-2025 | Preveleak |
| Ethicon US, LLC | $121.15 | 2024-2025 | Surgiflo Hemostatic Matrix, Vistaseal, Echelon; Endopath |
| Octapharma USA, INC. | $72.59 | 2024-2025 | Balfaxar, Fibryga |
| Abbott Laboratories | $70.04 | 2025 | Epic |
| Edwards Lifesciences Corporation | $62.02 | 2023-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Genentech USA, INC. | $60.82 | 2023-2024 | Tecentriq |
| Intuitive Surgical, INC. | $52.84 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $45.95 | 2023-2024 | |
| Lsi Solutions INC | $25.38 | 2024 | Cor-Knot |
| Astrazeneca Pharmaceuticals LP | $24.81 | 2024 | Tagrisso |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $24.50 | 2024 | Cardiocel |
| La Jolla Pharmaceutical Company | $23.94 | 2024 | Giapreza |
| Davol INC. | $23.57 | 2025 | Arista |
| Zimmer Biomet Holdings, INC. | $22.78 | 2025 | Sternalock |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Merck Sharp & Dohme LLC | $19.65 | 2024 | Keytruda |
| Stryker Corporation | $19.40 | 2024 | Spy-Phi System |
| Bolton Medical INC | $17.47 | 2024 | Treo Abdominal Stent-Graft System |
| Artivion, INC. | $16.35 | 2025 | Amds-Ascyrus Medical |
| Kls-Martin L.P. | $15.18 | 2024 | |
| Angiodynamics, INC. | $14.59 | 2024 | Alphavac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.